These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 7527763

  • 1. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.
    Markham A, Faulds D.
    Drugs; 1994 Sep; 48(3):455-84. PubMed ID: 7527763
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis.
    Geier SA, Klauss V, Matuschke A, Kronawitter U, Goebel FD.
    Ger J Ophthalmol; 1992 Sep; 1(2):110-3. PubMed ID: 1335812
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
    McGavin JK, Goa KL.
    Drugs; 2001 Sep; 61(8):1153-83. PubMed ID: 11465876
    [Abstract] [Full Text] [Related]

  • 8. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
    Parente F, Bianchi Porro G.
    Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
    [Abstract] [Full Text] [Related]

  • 9. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison.
    Blanshard C, Benhamou Y, Dohin E, Lernestedt JO, Gazzard BG, Katlama C.
    J Infect Dis; 1995 Sep; 172(3):622-8. PubMed ID: 7658052
    [Abstract] [Full Text] [Related]

  • 10. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y, Fujino Y, Ono A, Mochizuki M, Mouri H, Oka S, Kimura S, Shimada K.
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
    [Abstract] [Full Text] [Related]

  • 11. Combined ganciclovir and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients.
    Hardy WD.
    J Acquir Immune Defic Syndr (1988); 1991 Jul; 4 Suppl 1():S22-8. PubMed ID: 1848618
    [Abstract] [Full Text] [Related]

  • 12. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients.
    Cvetković RS, Wellington K.
    Drugs; 2005 Jul; 65(6):859-78. PubMed ID: 15819597
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus polyradiculopathy caused by a ganciclovir-resistant strain.
    Tokumoto JI, Hollander H.
    Clin Infect Dis; 1993 Nov; 17(5):854-6. PubMed ID: 8286625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.